Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review

(1) Background: Several phase II studies, including randomized controlled trials (RCTs), assessed the efficacy of adding androgen receptor signaling inhibitors (ARSIs) to androgen deprivation therapy (ADT) as a neoadjuvant treatment in patients treated with radical prostatectomy (RP) for prostate ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagisawa, Takafumi, Rajwa, Pawel, Quhal, Fahad, Kawada, Tatsushi, Bekku, Kensuke, Laukhtina, Ekaterina, von Deimling, Markus, Chlosta, Marcin, Karakiewicz, Pierre I., Kimura, Takahiro, Shariat, Shahrokh F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142264/
https://www.ncbi.nlm.nih.gov/pubmed/37109028
http://dx.doi.org/10.3390/jpm13040641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142264/
https://www.ncbi.nlm.nih.gov/pubmed/37109028
http://dx.doi.org/10.3390/jpm13040641

Ejemplares similares